These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33507975)

  • 1. Identification of drug combinations on the basis of machine learning to maximize anti-aging effects.
    Kim SK; Goughnour PC; Lee EJ; Kim MH; Chae HJ; Yun GY; Kim YR; Choi JW
    PLoS One; 2021; 16(1):e0246106. PubMed ID: 33507975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia.
    Zeng Z; Liu W; Tsao T; Qiu Y; Zhao Y; Samudio I; Sarbassov DD; Kornblau SM; Baggerly KA; Kantarjian HM; Konopleva M; Andreeff M
    Haematologica; 2017 Sep; 102(9):1537-1548. PubMed ID: 28659338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868.
    Jordheim LP; Plesa A; Dreano M; Cros-Perrial E; Keime C; Herveau S; Demangel D; Vendrell JA; Dumontet C
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):97-105. PubMed ID: 20844879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
    Canestraro M; Galimberti S; Savli H; Palumbo GA; Tibullo D; Nagy B; Guerrini F; Piaggi S; Cine N; Metelli MR; Petrini M
    Cancer Genet Cytogenet; 2010 Jun; 199(2):110-20. PubMed ID: 20471514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
    Pei S; Minhajuddin M; D'Alessandro A; Nemkov T; Stevens BM; Adane B; Khan N; Hagen FK; Yadav VK; De S; Ashton JM; Hansen KC; Gutman JA; Pollyea DA; Crooks PA; Smith C; Jordan CT
    J Biol Chem; 2016 Oct; 291(42):21984-22000. PubMed ID: 27573247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
    Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
    Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated microRNA-146a expression induced by granulocyte colony-stimulating factor enhanced low-dosage chemotherapy response in aged acute myeloid leukemia patients.
    Li X; Xu L; Sheng X; Cai J; Liu J; Yin T; Xiao F; Chen F; Zhong H
    Exp Hematol; 2018 Dec; 68():66-79.e3. PubMed ID: 30208330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data.
    Celebi R; Bear Don't Walk O; Movva R; Alpsoy S; Dumontier M
    Sci Rep; 2019 Jun; 9(1):8949. PubMed ID: 31222109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human circadian genes based on time course gene expression profiles by using a deep learning method.
    Cui P; Zhong T; Wang Z; Wang T; Zhao H; Liu C; Lu H
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2274-2283. PubMed ID: 29241666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.
    Nechiporuk T; Kurtz SE; Nikolova O; Liu T; Jones CL; D'Alessandro A; Culp-Hill R; d'Almeida A; Joshi SK; Rosenberg M; Tognon CE; Danilov AV; Druker BJ; Chang BH; McWeeney SK; Tyner JW
    Cancer Discov; 2019 Jul; 9(7):910-925. PubMed ID: 31048320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy.
    Medina D; David K; Lin Y; Schaar D; Patel V; Gharibo M; Bannerji R; Walton K; Aisner J; Rabson AB; Strair R
    Leuk Lymphoma; 2017 May; 58(5):1227-1230. PubMed ID: 27659510
    [No Abstract]   [Full Text] [Related]  

  • 13. Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.
    Eriksson A; Chantzi E; Fryknäs M; Gullbo J; Nygren P; Gustafsson M; Höglund M; Larsson R
    Leuk Res; 2017 Dec; 63():41-46. PubMed ID: 29100024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of treatment response using gene expression profiles.
    Korenberg MJ
    J Proteome Res; 2002; 1(1):55-61. PubMed ID: 12643527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells.
    Minderman H; Conroy JM; O'Loughlin KL; McQuaid D; Quinn P; Li S; Pendyala L; Nowak NJ; Baer MR
    Mol Cancer Ther; 2005 Jun; 4(6):885-900. PubMed ID: 15956246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-RACS: a handy tool to rank anti-cancer synergistic drugs.
    Yan X; Yang Y; Chen Z; Yin Z; Deng Z; Qiu T; Tang K; Cao Z
    Aging (Albany NY); 2020 Nov; 12(21):21504-21517. PubMed ID: 33173014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia.
    Chen SL; Hu F; Wang DW; Qin ZY; Liang Y; Dai YJ
    Aging (Albany NY); 2020 Jun; 12(12):11864-11877. PubMed ID: 32568101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated HIF-1α expression of acute myelogenous leukemia stem cells in the endosteal hypoxic zone may be a cause of minimal residual disease in bone marrow after chemotherapy.
    Matsunaga T; Imataki O; Torii E; Kameda T; Shide K; Shimoda H; Kamiunten A; Sekine M; Taniguchi Y; Yamamoto S; Hidaka T; Katayose K; Kubuki Y; Dobashi H; Bandoh S; Ohnishi H; Fukai F; Shimoda K
    Leuk Res; 2012 Jun; 36(6):e122-4. PubMed ID: 22444690
    [No Abstract]   [Full Text] [Related]  

  • 19. Boosting compound-protein interaction prediction by deep learning.
    Tian K; Shao M; Wang Y; Guan J; Zhou S
    Methods; 2016 Nov; 110():64-72. PubMed ID: 27378654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New agents for the treatment of acute myeloid leukemia.
    Tallman MS
    Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.